🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, non-blinded randomized phase III trial. Patients wil...
Status
Completed
Location
Spanish Breast Cancer Research Group
Start Date
1999-07
Trial ID
NCT00121992
Treatments Being Tested
This study was a phase Ib study of the safety and pharmacokinetics/pharmaco...
Status
Completed
Location
Fudan University Shanghai Cancer Center
Start Date
2014-02-25
Trial ID
NCT02522234
Treatments Being Tested
Previous studies have shown that TNBC is sensitive to DNA crosslinking-rela...
Status
Completed
Location
Henan Cancer Hospital
Start Date
2018-11-23
Trial ID
NCT04664972
Treatments Being Tested
Some sub-analysis has shown anthracycline-based regimens are not effective ...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2011-05
Trial ID
NCT01354522
Treatments Being Tested
RATIONALE: Triple-negative breast cancer (TNBC) is an aggressive subtype sh...
Status
Unknown
Location
Multiple Locations
Start Date
2015-07
Trial ID
NCT02464774
Treatments Being Tested
Primary objective of the study in patients without a sufficient sonographic...
Status
Completed
Location
Multiple Locations
Start Date
2002-09
Trial ID
NCT00544765
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Stanford University Medical Center
Start Date
1998-11
Trial ID
NCT00004175
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as docetaxel, doxorubicin , cyc...
Status
Completed
Location
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Start Date
2004-10
Trial ID
NCT00093795
Treatments Being Tested
This is a Phase 1b open-label, single arm, multicenter, study of ALRN-6924 ...
Status
Terminated
Location
Oncology and Hematology Associates of West Broward
Start Date
2023-01-09
Trial ID
NCT05622058
Treatments Being Tested
The main purpose of this study is to learn if adding bevacizumab to standar...
Status
Completed
Location
Birmingham Hematology and Oncology
Start Date
2009-05
Trial ID
NCT00887536
Treatments Being Tested